Tag: biosimilars safety monitoring
Adverse Event Monitoring for Biosimilars: How Safety Surveillance Works Today
Biosimilars require specialized safety monitoring due to their complex biology. Learn how adverse event reporting, traceability, and real-world surveillance systems ensure patient safety while expanding access to affordable biologic treatments.